Response to autografting and allografting
| Patient/sex . | Prior to auto . | After auto . | After allo . |
|---|---|---|---|
| 1. M | PR | CR | CR |
| 2. M | PR | CR | CR |
| 3. M | PR | PR | NE |
| 4. M | PR | PR | CR |
| 5. M | PR | PR | CR |
| 6. M | PR | CR | CR |
| 7. F | MR | MR | PR4-150 |
| 8. M | PR | PR | CR |
| 9. M | PR | PR | PR |
| 10. F | NC | NC | PR4-151 |
| 11. F | PR | PR | CR |
| 12. M | PR | PR | CR |
| 13. M | PR | PR | CR |
| 14. M | PR | PR | CR |
| 15. M | MR | MR | NE |
| 16. F | MR | PR | CR |
| 17. F | NC | NC | MR4-150 |
| Overall CR | 0% | 18% | 73% |
| Patient/sex . | Prior to auto . | After auto . | After allo . |
|---|---|---|---|
| 1. M | PR | CR | CR |
| 2. M | PR | CR | CR |
| 3. M | PR | PR | NE |
| 4. M | PR | PR | CR |
| 5. M | PR | PR | CR |
| 6. M | PR | CR | CR |
| 7. F | MR | MR | PR4-150 |
| 8. M | PR | PR | CR |
| 9. M | PR | PR | PR |
| 10. F | NC | NC | PR4-151 |
| 11. F | PR | PR | CR |
| 12. M | PR | PR | CR |
| 13. M | PR | PR | CR |
| 14. M | PR | PR | CR |
| 15. M | MR | MR | NE |
| 16. F | MR | PR | CR |
| 17. F | NC | NC | MR4-150 |
| Overall CR | 0% | 18% | 73% |